


Ask a doctor about a prescription for EDURANT 25 mg FILM-COATED TABLETS
Package Leaflet: Information for the User
EDURANT 25 mg film-coated tablets
rilpivirine
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack and other information:
EDURANT contains rilpivirine, which is used to treat Human Immunodeficiency Virus (HIV) infection. It belongs to a group of anti-HIV medicines called non-nucleoside reverse transcriptase inhibitors (NNRTIs). EDURANT works by reducing the amount of HIV in your body.
EDURANT is used in combination with other anti-HIV medicinesto treat adults and adolescents from 12 years of age infected with HIV who have not received anti-HIV medicines before.
Your doctor will explain which combination of medicines is right for you.
Do not take EDURANTif you are allergic to rilpivirine or any of the other ingredients of this medicine (listed in section 6).
Do not take EDURANT with any of the following medicinesas they may affect how EDURANT or the other medicine works:
If you are taking any of these medicines, consult your doctor for possible alternatives.
Warnings and precautions
Consult your doctor or pharmacist before starting EDURANT.
EDURANT does not cure HIV infection. It is part of a treatment that reduces the amount of virus in the blood. While taking this medicine, you can still transmit HIV to others, although effective antiviral treatment reduces the risk. Consult your doctor about the precautions needed to avoid infecting others.
EDURANT has only been used in a limited number of patients aged 65 years or older. If you belong to this age group, consult your doctor about using EDURANT.
Tell your doctor about your situation
Check the following points and tell your doctor if you are in any of these situations.
Children
EDURANT should not be used in children under 12 years of age, as it has not been studied in these patients.
Using EDURANT with other medicines
You must take EDURANT with other anti-HIV medicines. Your doctor will recommend which anti-HIV medicines can be combined with EDURANT and together decide which combination best suits your needs. Follow your doctor's instructions carefully.
Some medicines may affect the blood levels of EDURANT when taken at the same time as EDURANT.
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Do not combine EDURANT withother non-nucleoside reverse transcriptase inhibitors (NNRTIs) such as delavirdine, efavirenz, etravirine, and nevirapine.
The effects of EDURANT or other medicines may be affectedif you take
EDURANT with any of the following medicines. Tell your doctor if you are taking:
Pregnancy and breastfeeding
If you are pregnant or planning to become pregnant, inform your doctor immediately.
Pregnant women should discuss the use of EDURANT with their doctor.
Mothers infected with HIV should not breastfeed their babies, as there is a risk of transmitting the HIV infection through breast milk.
Consult your doctor or pharmacist before taking any medicine.
Driving and using machines
Some patients may experience fatigue, dizziness, or drowsiness during treatment with EDURANT. Do not drive or use machines if you feel fatigue, dizziness, or drowsiness while taking EDURANT.
EDURANT contains lactose
If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.
Always take this medicine exactly as your doctor or pharmacist has told you. If you are not sure, check with your doctor or pharmacist.
Instructions for correct use in adults and adolescents (12 to 18 years of age)The recommended dose of EDURANT is one tablet once a day.
EDURANT must be taken with a meal. It is important to take it with food to achieve the correct levels of the active substance in your body. A nutritional drink (even if high in protein) alone does not replace a meal.
There are four situations that require special attention:
Opening the child-resistant cap

The bottle has a child-resistant cap. It can be opened by pushing the cap and turning it at the same time in the opposite direction to the arrows.
If you take more EDURANT than you should
Tell your doctor or pharmacist immediately. In case of overdose, you may have a headache, nausea, dizziness, and/or abnormal dreams.
If you forget to take EDURANT
If you realize within 12 hours of the usual time you take EDURANT, take the tablet as soon as possible. The EDURANT tablet should be taken with a meal. Then take the next dose as usual. If you realize after 12 hours, do not take that dose and continue with the next doses as usual.
Do not take a double dose to make up for forgotten doses.
If you vomit and it has been less than 4 hours since taking EDURANT, take another tablet with food. If you vomit and it has been more than 4 hours after taking EDURANT, it is not necessary to take another tablet until the next scheduled dose.
Contact your doctor if you have any doubts about what to do if you forget a dose or vomit.
Do not stop taking EDURANT
HIV treatment does not cure HIV infection!Do not stop taking EDURANT or your other anti-HIV medicines without first discussing this with your doctor. Even if you feel better, do not stop taking EDURANT or your other anti-HIV medicines. If you do, you may increase the risk of developing resistance to the virus. Consult your doctor first.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Very common:
Common:
Uncommon:
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and on the bottle after "EXP". The expiry date refers to the last day of the month shown.
Store in the original bottle to protect from light.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Composition of EDURANT
Appearance and Package Contents
White to off-white, round, biconvex, film-coated tablet engraved with "TMC" on one side and "25" on the other.
Child-resistant bottle with 30 film-coated tablets.
Marketing Authorization Holder
Janssen-Cilag International NV
Turnhoutseweg 30
B-2340 Beerse
Belgium
Manufacturer
Janssen-Cilag SpA
Via C. Janssen
Borgo San Michele
04100 Latina
Italy
You can request more information about this medicinal product by contacting the local representative of the marketing authorization holder:
Belgium/Belgique/Belgien Janssen-Cilag NV Antwerpseweg 15-17 B-2340 Beerse Tel/Tél: +32 14 64 94 11 | Lithuania UAB "JOHNSON & JOHNSON" Konstitucijos pr. 21C LT-08130 Vilnius Tel: +370 5 278 68 88 |
Bulgaria Johnson & Johnson Bulgaria EOOD 4, Nikolay Haytov Str. 1766 Sofia Tel: +359 2 489 94 00 | Luxembourg/Luxemburg Janssen-Cilag NV Antwerpseweg 15-17 B-2340 Beerse Belgique/Belgien Tél/Tel: +32 14 64 94 11 |
Czech Republic Janssen-Cilag s.r.o. Walterovo námestí 329/1 CZ-158 00 Praha 5 - Jinonice Tel: +420 227 012 227 | Hungary Janssen-Cilag Kft. Nagyenyed u. 8-14 H-1123 Budapest Tel.: +36 1 884 2858 |
Denmark Janssen-Cilag A/S Bregnerødvej 133 DK-3460 Birkerød Tlf: +45 45 94 82 82 | Malta AM MANGION LTD. Mangion Building, Triq Gdida fi Triq Valletta MT-Hal-Luqa LQA 6000 Tel: +356 2397 6000 |
Germany Janssen-Cilag GmbH Johnson & Johnson Platz 1 D-41470 Neuss Tel: +49 2137 955 955 | Netherlands Janssen-Cilag B.V. Graaf Engelbertlaan 75 NL-4837 DS Breda Tel: +31 76 711 1111 |
Estonia UAB "JOHNSON & JOHNSON" Eesti filiaal Lõõtsa 2 EE-11415 Tallinn Tel: +372 617 7410 | Norway Janssen-Cilag AS Postboks 144 NO-1325-Lysaker Tlf: +47 24 12 65 00 |
Greece Janssen-Cilag Φαρμακευτική Α.Ε.Β.Ε. Λεωφόρος Ειρήνης 56 GR-151 21 Πεύκη, Αθήνα Tηλ: +30 210 80 90 000 | Austria Janssen-Cilag Pharma GmbH Vorgartenstraße 206B A-1020 Wien Tel: +43 1 610 300 |
Spain Janssen-Cilag, S.A. Paseo de las Doce Estrellas, 5-7 E-28042 Madrid Tel: +34 91 722 81 00 | Poland Janssen-Cilag Polska Sp. z o.o. ul. Ilzecka 24 PL-02-135 Warszawa Tel.: +48 22 237 60 00 |
France Janssen-Cilag 1, rue Camille Desmoulins, TSA 91003 F-92787 Issy Les Moulineaux, Cedex 9 Tél: 0 800 25 50 75 / +33 1 55 00 40 03 | Portugal Janssen-Cilag Farmacêutica, Lda. Lagoas Park, Edificio 9 PT-2740-262 Porto Salvo Tel: +351 214 368 600 |
Croatia Johnson & Johnson S.E. d.o.o. Oreškoviceva 6h 10010 Zagreb Tel: +385 1 6610 700 | Romania Johnson & Johnson România SRL Str. Tipografilor nr. 11-15 Cladirea S-Park, Corp B3-B4, Etaj 3 013714 Bucuresti, ROMÂNIA Tel: +40 21 207 1800 |
Ireland Janssen Sciences Ireland UC Barnahely Ringaskiddy IRL – Co. Cork P43 FA46 Tel: +353 1 800 709 122 | Slovenia Johnson & Johnson d.o.o. Šmartinska cesta 53 SI-1000 Ljubljana Tel: +386 1 401 18 00 |
Iceland Janssen-Cilag AB c/o Vistor hf. Hörgatúni 2 IS-210 Garðabær Sími: +354 535 7000 | Slovak Republic Johnson & Johnson s.r.o. CBC III, Karadžicova 12 SK-821 08 Bratislava Tel: +421 232 408 400 |
Italy Janssen-Cilag SpA Via M.Buonarroti, 23 I-20093 Cologno Monzese MI Tel: +39 02 2510 1 | Finland Janssen-Cilag Oy Vaisalantie/Vaisalavägen 2 FI-02130 Espoo/Esbo Puh/Tel: +358 207 531 300 |
Cyprus Βαρνάβας Χατζηπαναγής Λτδ, Λεωφόρος Γιάννου Κρανιδιώτη 226 Λατσι CY-2234 Λευκωσία Τηλ: +357 22 207 700 | Sweden Janssen-Cilag AB Box 4042 SE-16904 Solna Tel: +46 8 626 50 00 |
Sweden Janssen-Cilag AB Box 4042 SE-16904 Solna Tel: +46 8 626 50 00 | United Kingdom Janssen-Cilag Ltd. 50-100 Holmers Farm Way High Wycombe Buckinghamshire HP12 4EG - UK Tel: +44 1 494 567 444 |
Date of Last Revision of this Leaflet: {MM/YYYY}.
Detailed information on this medicinal product is available on the European Medicines Agency website: http://www.ema.europa.eu/.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for EDURANT 25 mg FILM-COATED TABLETS – subject to medical assessment and local rules.